首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:South asian journal of cancer

缩写:

ISSN:2278-330X

e-ISSN:2278-4306

IF/分区:0.6/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引955
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ajit Singh Oberoi,C R Selvasekar,S R Murali et al. Ajit Singh Oberoi et al.
Background: International medical graduates (IMGs) play a crucial role in the United Kingdom National Health Service (NHS), yet they encounter significant challenges adapting to the NHS environment. This study aims to ide...
Shyam Aggarwal,Anuradha Chougle,Vineet Talwar et al. Shyam Aggarwal et al.
The majority of patients with colorectal cancer (CRC) will ultimately develop metastasis. Identifying specific molecular characteristics in them can help optimize their management in a personalized manner. This requires a noninvasive method...
Saumitra Rawat,Shyam Aggarwal,Purvish M Parikh et al. Saumitra Rawat et al.
Complete mesocolic excision (CME) for colorectal cancer builds on the success of total mesorectal excision (TME), the international gold standard for rectal cancer. In TME, removal of the primary tumor along with associated mesocolon and ac...
S P Somashekhar,Adwaith Krishna Surendran,Deep Goyal et al. S P Somashekhar et al.
Accounting for 8.7% of global cancer deaths, colorectal cancer (CRC) is one of the leading causes of cancer-related mortality. Cytoreduction surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is part of a multimod...
Shyam Aggarwal,Viraj Lavingiya,Vamshi Krishna et al. Shyam Aggarwal et al.
Srinath Bhradwaj R,Aditya Sarin,Shyam Aggarwal et al. Srinath Bhradwaj R et al.
A major advance in rectal cancer was the evidence supporting short-course radiotherapy and long-course chemoradiotherapy. Both have been shown to improve local outcomes. Total neoadjuvant therapy (TNT) is the new kid on the block that provi...
Himanshi Bhanu,Ruchi Mittal,Urmila Senapati Himanshi Bhanu
Colorectal carcinoma (CRC) stands as one of the most prevalent malignant neoplasms, carrying significant morbidity and mortality implications. Within colorectal carcinogenesis, cancer stem cells are recognized as key contributors, infusing ...
Sagarika Sarkar,Rena Guha,Sudipta Chakrabarti Sagarika Sarkar
Purpose: Very few studies have assessed tumor budding (TB) and poorly differentiated cell clusters (PDCs) simultaneously in colorectal cancers (CRCs). The goal of this study was to establish a correlation between these tw...
Prasad Narayanan,Shyam Aggarwal,Manish Singhal et al. Prasad Narayanan et al.
A significant number of patients with colorectal cancer (CRC) benefit from adjuvant therapy. While 6 months of FOLFOX is standard of care, newer regimens like CAPOX and SOX allow for shorter durations. Trials of importance include SCOT (U.K...
Sheikh Mohammad Taha Mustafa,Deepak Govil,Vijay Arora et al. Sheikh Mohammad Taha Mustafa et al.
Transanal minimally invasive surgery (TAMIS) is considered a standard of care in rectal cancers. Its advantage is that it is organ preserving. Its main role is in early-stage cancers limited to the rectum (T1N0M0). Regular follow-up with co...